Natco Pharma

Market Cap (₹ Cr.)

₹24,469

52 Week High

1,639.00

Book Value

₹327

52 Week Low

752.45

PE Ratio

12.58

PB Ratio

3.42

PE for Sector

37.21

PB for Sector

3.95

ROE

14.68 %

ROCE

28.53 %

Dividend Yield

0.70 %

EPS

₹91.37

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Indian - Bulk Drugs & Formln

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

46.78 %

Net Income Growth

94.09 %

Cash Flow Change

42.69 %

ROE

61.61 %

ROCE

78.02 %

EBITDA Margin (Avg.)

23.10 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Revenue	178	197	213	264	393	314	452	664	541	416	413	552	750	551	562	556	447	485	492	479	459	552	506	356	341	406	371	561	525	839	367	432	799	1,063	955	655	1,001	1,277	1,344
Expenses	117	134	150	192	298	229	341	396	301	273	283	254	353	291	292	322	266	269	321	321	302	360	389	253	235	280	281	442	552	426	281	346	454	545	488	387	512	474	502
EBITDA	62	63	64	71	96	86	111	268	241	143	130	298	397	261	271	234	181	216	171	158	157	193	118	103	106	126	90	119	-27	413	86	86	345	518	467	268	489	803	842
Operating Profit %	30 %	28 %	27 %	22 %	24 %	26 %	24 %	40 %	45 %	34 %	31 %	53 %	52 %	44 %	44 %	40 %	36 %	42 %	30 %	28 %	28 %	32 %	19 %	24 %	25 %	29 %	15 %	17 %	-7 %	47 %	20 %	16 %	42 %	48 %	48 %	38 %	47 %	62 %	61 %
Depreciation	11	11	11	12	12	13	14	14	13	15	16	17	18	18	20	21	21	22	22	25	30	28	28	29	30	33	34	36	36	37	38	38	38	40	40	40	52	40	42
Interest	9	8	8	3	3	3	4	4	6	4	4	4	3	3	4	7	5	6	6	5	4	3	3	3	2	2	3	4	4	3	2	3	1	3	3	4	5	4	3
Profit Before Tax	42	44	45	56	80	70	93	250	221	125	110	276	376	240	247	206	154	188	144	127	124	162	87	71	73	91	52	80	-67	373	46	45	306	475	424	224	433	758	797
Tax	8	10	10	13	11	19	18	53	50	27	24	59	108	65	55	51	16	41	33	30	26	41	21	7	24	16	10	14	-7	66	9	8	50	84	75	42	84	132	148
Net Profit	65	34	34	43	69	51	70	197	177	97	87	217	296	189	193	162	123	148	122	104	101	127	71	55	57	75	54	72	-61	308	38	37	254	405	360	192	349	636	661
EPS in ₹	19.59	10.20	10.55	2.50	3.86	2.92	3.96	11.29	10.13	5.58	4.98	12.33	16.05	10.22	10.47	8.78	6.73	8.11	6.72	5.70	5.55	6.96	3.89	3.00	3.14	4.12	2.94	3.93	-3.36	16.87	2.07	2.04	13.92	22.43	20.11	10.72	19.49	35.53	36.91

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,395	1,843	2,347	3,736	4,356	4,647	4,753	4,978	5,388	6,554
Fixed Assets	573	706	829	1,015	1,215	1,575	2,006	2,174	2,234	2,287
Current Assets	444	791	1,035	2,054	2,267	2,240	2,169	2,168	2,495	3,410
Capital Work in Progress	101	212	336	480	638	518	223	129	63	134
Investments	0	94	95	150	244	191	337	550	658	742
Other Assets	721	831	1,087	2,091	2,259	2,363	2,186	2,125	2,434	3,392
Total Liabilities	516	506	647	611	793	777	661	786	686	962
Current Liabilities	398	479	610	564	710	660	519	651	569	886
Non Current Liabilities	118	28	38	47	83	118	143	135	117	76
Total Equity	879	1,336	1,700	3,125	3,563	3,870	4,091	4,192	4,702	5,592
Reserve & Surplus	846	1,302	1,665	3,089	3,527	3,833	4,055	4,155	4,666	5,557
Share Capital	33	35	35	37	37	36	37	37	37	36

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-1	93	-6	-3	1	-4	-3	1	1	-1
Investing Activities	-148	-248	-291	-1,131	-645	-165	-3	-92	-437	-960
Operating Activities	125	190	330	476	699	422	184	58	784	1,196
Financing Activities	23	151	-46	652	-52	-261	-183	36	-347	-237

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Promoter	48.87 %	48.87 %	48.87 %	48.86 %	48.81 %	48.80 %	48.80 %	48.82 %	48.84 %	49.76 %	49.71 %	49.71 %	49.71 %	49.71 %	49.62 %
FIIs	16.34 %	0.00 %	12.50 %	12.23 %	11.94 %	11.65 %	11.67 %	11.72 %	11.91 %	11.02 %	12.82 %	13.72 %	16.14 %	17.45 %	17.51 %
DIIs	16.14 %	29.94 %	17.81 %	18.11 %	16.15 %	15.29 %	14.31 %	14.93 %	15.38 %	15.15 %	14.01 %	11.25 %	9.70 %	7.87 %	6.75 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	18.65 %	21.19 %	20.82 %	20.80 %	23.10 %	24.25 %	25.23 %	24.53 %	23.87 %	24.07 %	23.46 %	25.32 %	24.45 %	24.97 %	26.12 %

Show % Change

Dividend History

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,779.10	4,25,929.94	38.00	49,887.17	12.06	9,648	27.35	40.28
Cipla	1,467.00	1,18,825.56	25.74	26,520.66	14.17	4,155	12.95	38.47
Mankind Pharma	2,521.85	1,02,885.42	48.65	10,615.63	19.57	1,942	28.89	46.80
Dr Reddys Laboratories	1,199.75	1,01,290.13	18.97	28,905.40	12.36	5,578	-9.47	32.64
Zydus Life Science	943.20	95,280.30	22.27	19,831.50	13.82	3,831	14.57	32.02
Lupin	2,051.10	92,929.19	35.38	20,141.50	19.94	1,936	73.52	37.01
Aurobindo Pharma	1,234.05	73,119.28	20.05	29,559.25	17.55	3,169	8.65	20.74
Alkem Laboratories	5,635.80	66,062.65	30.38	12,978.42	9.84	1,811	14.16	35.74
Glenmark Pharmaceuticals	1,474.50	42,112.35	-	12,653.09	6.58	-1,831	675.84	30.08
IPCA Laboratories	1,579.00	39,910.21	59.43	7,829.81	22.92	529	80.05	52.38